Tom Frinzi to become CEO of STAAR Surgical
Click Here to Manage Email Alerts
Caren Mason will retire as president and CEO of STAAR Surgical on Dec. 31, with Thomas “Tom” G. Frinzi tapped as her replacement.
Mason has served in her role since March 2015 and will act in an advisory role until Dec. 31, 2023, according to a company press release.
Source: Adobe Stock.
“Serving as CEO of STAAR Surgical has been the highlight of my career,” Mason said in the release. “I am proud of STAAR’s accomplishments under my leadership over the past 7 years, and I am grateful for the many dedicated professionals around the world who make STAAR such a phenomenal company. I look forward to watching STAAR’s continued success and have great confidence in Tom and the amazing STAAR leadership team.”
Frinzi has been on STAAR’s board of directors since June 2020 and previously served in executive leadership roles at Johnson & Johnson Vision and Abbott Laboratories, among other companies in the ophthalmic and medical device industries.
“I am honored to be selected to lead STAAR as CEO and excited about our company’s future, especially our significant opportunity launching EVO ICL in the United States,” Frinzi said in the release. “Caren has set the company on extremely strong footing, and I will be highly focused on continuing our global growth and ensuring STAAR continues to lead the industry with innovative lens-based solutions that offer freedom from glasses and contact lenses. We have an incredibly strong team, a life-transforming solution for patients, and we are well positioned to continue to deliver for patients and the physicians who serve them, while also driving value for our shareholders.”
Read more about
Click Here to Manage Email Alerts